DK115789D0 - Farmaceutisk middel til oral indtagelse, isaer til jern- og magnesiumsubstitutionstetapi - Google Patents

Farmaceutisk middel til oral indtagelse, isaer til jern- og magnesiumsubstitutionstetapi

Info

Publication number
DK115789D0
DK115789D0 DK115789A DK115789A DK115789D0 DK 115789 D0 DK115789 D0 DK 115789D0 DK 115789 A DK115789 A DK 115789A DK 115789 A DK115789 A DK 115789A DK 115789 D0 DK115789 D0 DK 115789D0
Authority
DK
Denmark
Prior art keywords
iron
magnesium
tapi
israel
oral administration
Prior art date
Application number
DK115789A
Other languages
English (en)
Other versions
DK115789A (da
Inventor
Joachim Helbig
Hans Georg Classen
Original Assignee
Verla Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Verla Pharm filed Critical Verla Pharm
Publication of DK115789D0 publication Critical patent/DK115789D0/da
Publication of DK115789A publication Critical patent/DK115789A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DK115789A 1988-03-22 1989-03-09 Farmaceutisk middel til oral indtagelse, isaer til jern- og magnesiumsubstitutionstetapi DK115789A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3809625A DE3809625A1 (de) 1988-03-22 1988-03-22 Oral verabreichbares pharmazeutisches mittel, insbesondere zur eisen- und magnesiumsubstitutionstherapie

Publications (2)

Publication Number Publication Date
DK115789D0 true DK115789D0 (da) 1989-03-09
DK115789A DK115789A (da) 1989-09-23

Family

ID=6350387

Family Applications (1)

Application Number Title Priority Date Filing Date
DK115789A DK115789A (da) 1988-03-22 1989-03-09 Farmaceutisk middel til oral indtagelse, isaer til jern- og magnesiumsubstitutionstetapi

Country Status (8)

Country Link
US (1) US5143732A (da)
EP (1) EP0334177B1 (da)
AT (1) ATE123416T1 (da)
DE (2) DE3809625A1 (da)
DK (1) DK115789A (da)
ES (1) ES2072270T3 (da)
PT (1) PT90096B (da)
ZA (1) ZA892023B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4201504C2 (de) * 1992-01-21 1997-04-30 Protina Chemische Ges Mbh Magnesiumpräparat
DE19504936C1 (de) * 1995-02-15 1996-05-15 Woerwag Pharma Gmbh Arzneimittel auf der Grundlage von Magnesiumchlorid
WO2000033818A1 (en) 1998-12-11 2000-06-15 Nostrum Pharmaceuticals, Inc. Sustained release tablet containing hydrocolloid and cellulose ether
US6887897B2 (en) 2001-07-31 2005-05-03 Mission Pharmacal Company Calcium glutarate supplement and phosphorus binder
US6579905B1 (en) * 2001-11-19 2003-06-17 Mcmains Michael B. Method for the prevention or treatment of hypomagnesemia in pediatric patients and in patients with G-tubes or NG-tubes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH294891A (de) * 1949-06-30 1953-11-30 Hilppa Pirhonen Verfahren zur Herstellung von Nährsalzpräparaten.
JPS57156419A (en) * 1981-03-24 1982-09-27 Kyowa Chem Ind Co Ltd Remedy for sideropenia
DE3238118A1 (de) * 1982-10-14 1984-04-19 Verla-Pharm, Arzneimittelfabrik Apotheker H.J. v. Ehrlich GmbH & Co KG, 8132 Tutzing Verfahren zur herstellung von komplexverbindungen aus aminodicarbonsaeuren, zweiwertigen metallionen und halogenidionen
JPS606619A (ja) * 1983-06-27 1985-01-14 Kyowa Chem Ind Co Ltd 鉄分欠乏症処置剤及びその製法
US4751085A (en) * 1984-08-29 1988-06-14 Gaull Gerald E Human nutritional compositions containing taurine and vitamins and/or minerals

Also Published As

Publication number Publication date
EP0334177A2 (de) 1989-09-27
DE3809625C2 (da) 1990-03-22
ES2072270T3 (es) 1995-07-16
DE58909272D1 (de) 1995-07-13
ATE123416T1 (de) 1995-06-15
PT90096A (pt) 1989-11-10
DK115789A (da) 1989-09-23
EP0334177B1 (de) 1995-06-07
DE3809625A1 (de) 1989-10-05
ZA892023B (en) 1989-11-29
US5143732A (en) 1992-09-01
PT90096B (pt) 1994-10-31
EP0334177A3 (en) 1990-05-30

Similar Documents

Publication Publication Date Title
WO1997049373A3 (en) Treatment and prevention of hiv infection by administration of derivatives of human chorionic gonadotropin
DE59102210D1 (de) Galanthemin enthaltende pharmazeutische Formulierung zur Behandlung des Alkoholismus.
RU93045710A (ru) Противовирусная нуклеозидная композиция, способ ее получения и способ лечения
ATE83374T1 (de) Neue galenische form von fenofibrat.
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
KR870005637A (ko) 약물 데포
BG101118A (en) Therapeutical compounds
CA2004239A1 (en) Use of acetyl d-carnitine in the therapeutic treatment of glaucoma, and pharmaceutical compositions useful in such treatment
LU90234I2 (fr) Une combination comprenant de la lamivudine facultativement sous la forme d'un sel pharmaceutiquement acceptable et de la zidovudine
ATE75945T1 (de) Pharmazeutische zubereitung zur behandlung des diabetes mellitus.
MY111260A (en) Pharmaceutical composition for the treatment of nicotine dependence
BG105173A (en) Novel salt form of pantoprazole
DE69404116D1 (de) Mit Zucker überzogene pharmazeutische Dosierungseinheit
SE9002500D0 (sv) Farmaceutisk, nac-innehaallande komposition foer oral administrering
MX9203417A (es) Compuestos de diarilo antiateroescleroticos.
CA2135614A1 (en) Use of urodilatin in pulmonary and bronchial diseases
ATE69164T1 (de) Arzneimittel zur behandlung von uraemie.
DK115789A (da) Farmaceutisk middel til oral indtagelse, isaer til jern- og magnesiumsubstitutionstetapi
ZA885590B (en) Pharmaceutical composition intended for the prevention and treatment of bacterial or viral diseases
DK0538690T3 (da) Arylquinolyl-substituerede 1,4-dihydropyridin-dicarboxylsyrederivater, fremgangsmåde til deres fremstilling af deres anvendelse i lægemidler
EP0523013A3 (en) Use of benzimidazoline-2-oxo-1-carboxylic acid derivatives in the treatment of organic mental diseases
UA41326C2 (uk) Фармацевтична композиція для профілактики або лікування вірусних захворювань, засіб для профілактики або лікування вірусних захворювань
MX9206738A (es) Forma de dosis unitaria de subsalicato de bismuto.
MX9401370A (es) Terapia antiviral.
IT1243368B (it) Uso del bendazac e dei suoi sali farmaceuticamente accettabili

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment